https://www.kuball-laboratories.com/jurgen-kuball

http://nl.linkedin.com/pub/jurgen-kuball/88/156/49b

Prof. Dr. Jürgen Kuball received his medical degree as hematologists at the University of Mainz, Germany, and was further trained at the Fred Hutchinson Cancer Center in Seattle, WA, USA. Prof. Kuball joined the Department of Hematology at the University Medical Center in Utrecht in The Netherlands in 2007 as hematologists and immunologist. He became a VIDI-laureate in 2010 and chairs the section applied & tumor-immunology within the laboratory of translation immunology. Since 2013 he is chairing the Department of Hematology (adults). His clinical activities are focusing on treating patients with hematological malignancies including stem cell transplantation. His clinical-translational efforts and patient care are driven by his role as Director of the Bone Marrow Transplantation Program at the University Medical Center Utrecht, as well as active membership of the leukemia working party and stem cell working party of HOVON. His current laboratory activities are focusing on the understanding of innate immune cells and their receptors to recognize malignant cells and virally infected cells as well as the genetic engineering of a transplant.

For more information on experimental and translational research please visit Kuball Laboratories

Board activities

• Chair Immunology Community Utrecht Life Science 2023-
• Secretary-Team of GoCART Coalition 2023-
• EBMT Chair Legal and Regulatory Affairs Committee 2019-
• HOVON General board 2014-
• KWF PPS commissie 2022-
• KWF adviesraad  2016-2022
• Wetenschappelijke raad KIKA 2018-2021

Translational Valorisation

• Cofounder and shareholder of Gadeta  2015- 2023
• Patent holder on multipe inventions  licensed to Gadeta and Miltenyi Biotech  2012-
• Receiving revenues from licensed patents in the field of genetic engineering 2021-

Memberships

• ASH
• EBMT
• EHA Member
• HOVON Leukemia working party
• HOVON SCT working party 

External positions

• Scientific advisor, GADETA, 2018 → 2020
• Scientific Advisory Board, JAZZ pharmaceuticals, 11 Sep 2016
• Scientific cofounder and CSO, GADETA, 2015 → 2018
• Grant Support, speaker and joint patent application, Miltenyi Biotec, 2015 → …
• Grant and Scientific advisory board, Novartis, 2015 → …

American Association of Cancer Research-GlaxoSmithKline Scholar in Cancer Research Award (2001)
Stipendiat der Deutschen Krebshilfe (2005-2007)
Team Science recognition award of the „Society for Immunotherapy of Cancer“ to Jürgen Kuball and the University of Washington, USA (2010)
VIDI-Laureate ZonMW, The Netherlands (2010)